Time course of prepulse inhibition disruption induced by dopamine agonists and NMDA antagonists: Effects of drug administration regimen

Pharmacology Biochemistry and Behavior

Volumn 99, Issue 3, 2011, Pages 509-518

  Li, Ming ^a   He, Wei ^a   Chen, Jing ^a,b  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Dizocilpine (MK 801); Prepulse inhibition of acoustic startle; Quinpirole; Repeated amphetamine treatment; Repeated phencyclidine treatment; Sensitization effect; Tolerance effect

Indexed keywords

AMPHETAMINE; DIZOCILPINE; DOPAMINE RECEPTOR STIMULATING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; QUINPIROLE;

ACOUSTIC STARTLE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; HABITUATION; MALE; MEDICAL PARAMETERS; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; STARTLE REFLEX;

ACOUSTIC STIMULATION; ANIMALS; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; MALE; NEURAL INHIBITION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; STARTLE REACTION; TIME FACTORS;

ANIMALIA; RATTUS;

EID: 79959840031     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.05.001     Document Type: Article

References (43)

1. Anagnostaras SG, Robinson TE. Sensitization to the psychomotor stimulant effects of amphetamine: modulation by associative learning. Behav Neurosci 1996;110:1397-414. (Pubitemid 27009202)
2. Angrist B. Amphetamine psychosis: clinical variations of the syndrome. In: Cho A, Segal D, editors. Amphetamine and its analogues. San Diego: Academic Press; 1994. p. 387-414.
3. Bell DS. Comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry 1965;111:701-7.
4. Braff DL, Geyer MA. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 1990;47:181-8.
5. Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead KS, et al. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res 2001;49:171-8. (Pubitemid 32434323)
6. Byrnes JJ, Hammer RP. The disruptive effect of cocaine on prepulse inhibition is prevented by repeated administration in rats. Neuropsychopharmacology 2000;22:551-4. (Pubitemid 30145624)
7. Culm KE, Hammer Jr RP. Recovery of sensorimotor gating without G protein adaptation after repeated D2-like dopamine receptor agonist treatment in rats. J Pharmacol Exp Ther 2004;308:487-94. (Pubitemid 38134209)
8. Culm KE, Lugo-Escobar N, Hope BT, Hammer Jr RP. Repeated quinpirole treatment increases cAMP-dependent protein kinase activity and CREB phosphorylation in nucleus accumbens and reverses quinpirole-induced sensorimotor gating deficits in rats. Neuropsychopharmacology 2004;29:1823-30. (Pubitemid 39336794)
9. Davis JM, Schlemmer Jr FP. The amphetamine psychosis. In: Caldwell J, editor. Amphetamines and related stimulants: chemical, biological, clinical and social aspects. Boca Raton, FL: CRC Press; 1980. p. 161-73.
10. Druhan JP, Geyer MA, Valentino RJ. Lack of sensitization to the effects of D-amphetamine and apomorphine on sensorimotor gating in rats. Psychopharmacology (Berl) 1998;135:296-304. (Pubitemid 28055466)
11. Ellinwood Jr EH, Sudilovsky A, Nelson LM. Evolving behavior in the clinical and experimental amphetamine (model) psychosis. Am J Psychiatry 1973;130:1088-93.
12. Feifel D, Priebe K, Johnstone-Miller E, Morgan CJ. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning. Psychopharmacology (Berl) 2002;162:138-46. (Pubitemid 34743953)
13. Fletcher PJ, Tenn CC, Rizos Z, Lovic V, Kapur S. Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex. Psychopharmacology (Berl) 2005;183:190-200. (Pubitemid 41609271)
14. Geyer MA, Braff DL. Startle habituation and sensorimotor gating in schizophrenia and related animal models. Schizophr Bull 1987;13:643-68. (Pubitemid 18037659)
15. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 2001;156:117-54. (Pubitemid 32702206)
16. Griffith JD, Cavanaugh J, Held J, Oates JA. Dextroamphetamine. Evaluation of psychomimetic properties in man. Arch Gen Psychiatry 1972;26:97-100.
17. Hedou G, Homberg J, Feldon J, Heidbreder CA. Expression of sensitization to amphetamine and dynamics of dopamine neurotransmission in different laminae of the rat medial prefrontal cortex. Neuropharmacology 2001;40:366-82. (Pubitemid 32144715)
18. Janowsky DS, Risch C. Amphetamine psychosis and psychotic symptoms. Psychopharmacology (Berl) 1979;65:73-7. (Pubitemid 10234634)
19. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991;148:1301-8.
20. Mansbach RS, Geyer MA. Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology 1989;2:299-308. (Pubitemid 20025258)
21. Mansbach RS, Geyer MA, Braff DL. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berl) 1988;94:507-14. (Pubitemid 18087401)
22. Martin-IversonMT.Does sensitization occur to prepulse inhibition of the startle reflex effects of repeated apomorphine treatments in rats? J Psychopharmacol 1999;13:261-73.
23. Martinez V, Parikh V, Sarter M. Sensitized attentional performance and Fos-immunoreactive cholinergic neurons in the basal forebrain of amphetamine-pretreated rats. Biol Psychiatry 2005;57:1138-46. (Pubitemid 40615775)
24. Martinez ZA, Ellison GD, Geyer MA, Swerdlow NR. Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats. Neuropsychopharmacology 1999;21:28-39. (Pubitemid 29253833)
25. Murphy CA, Di Iorio L, Feldon J. Effects of psychostimulant withdrawal on latent inhibition of conditioned active avoidance and prepulse inhibition of the acoustic startle response. Psychopharmacology (Berl) 2001a;156:155-64. (Pubitemid 32702207)
26. Murphy CA, Fend M, Russig H, Feldon J. Latent inhibition, but not prepulse inhibition, is reduced during withdrawal from an escalating dosage schedule of amphetamine. Behav Neurosci 2001b;115:1247-56. (Pubitemid 33139132)
27. Nestler EJ. Molecular neurobiology of addiction. Am J Addict 2001;10:201-17. (Pubitemid 32879087)
28. Paulson PE, Robinson TE. Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse 1995;19:56-65.
29. Peleg-Raibstein D, Sydekum E, Feldon J. Differential effects on prepulse inhibition of withdrawal from two different repeated administration schedules of amphetamine. Int J Neuropsychopharmacol 2006;9:737-49. (Pubitemid 46122773)
30. Robinson TE, Becker JB. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 1986;396:157-98. (Pubitemid 16100809)
31. Russig H, Murphy CA, Feldon J. Prepulse inhibition during withdrawal from an escalating dosage schedule of amphetamine. Psychopharmacology (Berl) 2003;169:340-53. (Pubitemid 37264945)
32. Schulz B, Fendt M, Pedersen V, Koch M. Sensitization of prepulse inhibition deficits by repeated administration of dizocilpine. Psychopharmacology (Berl) 2001;156:177-81. (Pubitemid 32702210)
33. Schwabe K, Brosda J, Wegener N, Koch M. Clozapine enhances disruption of prepulse inhibition after sub-chronic dizocilpine- or phencyclidine-treatment in Wistar rats. Pharmacol Biochem Behav 2005;80:213-9. (Pubitemid 40170419)
34. Segal DS, Geyer MA, Schuckit MA. Stimulant-induced psychosis: an evaluation of animal methods. Essays Neurochem Neuropharmacol 1981;5:95-129.
35. Segal DS, Kuczenski R. An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics. J Neurosci 1997;17:2551-66.
36. Segal DS, Mandell AJ. Long-term administration of D-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav 1974;2:249-55.
37. Simon SL, Richardson K, Dacey J, Glynn S, Domier CP, Rawson RA, et al. A comparison of patterns of methamphetamine and cocaine use. J Addict Dis 2002;21:35-44. (Pubitemid 35203852)
38. Swerdlow NR, Braff DL, Geyer MA. Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol 2000;11:185-204. (Pubitemid 30449750)
39. Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) 2008;199:331-88.
40. Tenn CC, Fletcher PJ, Kapur S. Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia. Schizophr Res 2003;64:103-14. (Pubitemid 37412332)
41. Tenn CC, Kapur S, Fletcher PJ. Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition. Psychopharmacology (Berl) 2005;180:366-76. (Pubitemid 40909683)
42. Varty GB, Higgins GA. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacology (Berl) 1995;122:15-26.
43. Zhang J, Engel JA, Soderpalm B, Svensson L. Repeated administration of amphetamine induces sensitisation to its disruptive effect on prepulse inhibition in the rat. Psychopharmacology (Berl) 1998;135:401-6. (Pubitemid 28254847)